PACT- and RIG-I-dependent activation of type I interferon production by a defective interfering RNA derived from measles virus vaccine

Journal of Virology

Volumn 90, Issue 3, 2016, Pages 1557-1568

  Ho, Ting Hin ^a   Kew, Chun ^a   Lui, Pak Yin ^a   Chan, Chi Ping ^a   Satoh, Takashi ^b   Akira, Shizuo ^b   Jin, Dong Yan ^a   Kok, Kin Hang ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MDA5 PROTEIN; PACT PROTEIN; RANTES; RETINOIC ACID INDUCIBLE PROTEIN I; UNCLASSIFIED DRUG; VIRUS PROTEIN; DDX58 PROTEIN, HUMAN; DEAD BOX PROTEIN; MEASLES VACCINE; PRKRA PROTEIN, HUMAN; RNA BINDING PROTEIN; VIRUS RNA;

ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; INNATE IMMUNITY; INTERFERON PRODUCTION; MEASLES VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN RNA BINDING; RNA FOLDING; RNA INTERFERENCE; RNA REPLICATION; BIOSYNTHESIS; CELL LINE; CHEMISTRY; CONFORMATION; GENETICS; IMMUNOLOGY; METABOLISM; MOLECULAR MODEL; SATELLITE VIRUS;

CELL LINE; DEAD BOX PROTEIN 58; DEAD-BOX RNA HELICASES; DEFECTIVE VIRUSES; HUMANS; INTERFERON-BETA; MEASLES VACCINE; MEASLES VIRUS; MODELS, MOLECULAR; NUCLEIC ACID CONFORMATION; RNA, VIRAL; RNA-BINDING PROTEINS;

EID: 84958092972     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02161-15     Document Type: Article

References (72)

1. Moresco EM, LaVine D, Beutler B. 2011. Toll-like receptors. Curr Biol 21:R488-R493. http://dx.doi.org/10.1016/j.cub.2011.05.039.
2. Kawai T, Akira S. 2011. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34:637-650. http://dx.doi.org/10.1016/j.immuni.2011.05.006.
3. Wu J, Chen ZJ. 2014. Innate immune sensing and signaling of cytosolic nucleic acids. Annu Rev Immunol 32:461-488. http://dx.doi.org/10.1146/annurev-immunol-032713-120156.
4. Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, Miyagishi M, Taira K, Akira S, Fujita T. 2004. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 5:730-737. http://dx.doi.org/10.1038/ni1087.
5. Hornung V, Ellegast J, Kim S, Brzózka K, Jung A, Kato H, Poeck H, Akira S, Conzelmann KK, Schlee M, Endres S, Hartmann G. 2006. 5'-triphosphate RNA is the ligand for RIG-I. Science 314:994-997. http://dx.doi.org/10.1126/science.1132505.
6. Schmidt A, Schwerd T, Hamm W, Hellmuth JC, Cui S, Wenzel M, Hoffmann FS, Michallet MC, Besch R, Hopfner KP, Endres S, Rothenfusser S. 2009. 5'-triphosphate RNA requires base-paired structures to activate antiviral signaling via RIG-I. Proc Natl Acad SciUSA106:12067-12072. http://dx.doi.org/10.1073/pnas.0900971106.
7. Goubau D, Schlee M, Deddouche S, Pruijssers AJ, Zillinger T, Goldeck M, Schuberth C, Van der Veen AG, Fujimura T, Rehwinkel J, Iskarpatyoti JA, Barchet W, Ludwig J, Dermody TS, Hartmann G, Reis e Sousa C. 2014. Antiviral immunity via RIG-I-mediated recognition of RNA bearing 5'-diphosphates. Nature 514:372-375. http://dx.doi.org/10.1038/nature13590.
8. Kok KH, Lui PY, Ng MH, Siu KL, Au SWN, Jin DY. 2011. The double-stranded RNA-binding protein PACT functions as a cellular activator of RIG-I to facilitate innate antiviral response. Cell Host Microbe 9:299-309. http://dx.doi.org/10.1016/j.chom.2011.03.007.
9. Naniche D, Yeh A, Eto D, Manchester M, Friedman RM, Oldstone MBA. 2000. Evasion of host defenses by measles virus: wild-type measles virus infection interferes with induction of α/β interferon production. J Virol 74:7478-7484. http://dx.doi.org/10.1128/JVI.74.16.7478-7484.2000.
10. Shingai M, Ebihara T, Begum NA, Kato A, Honma T, Matsumoto K, Saito H, Ogura H, Matsumoto M, Seya T. 2007. Differential type I IFN-inducing abilities of wild-type versus vaccine strains of measles virus. J Immunol 179:6123-6133. http://dx.doi.org/10.4049/jimmunol.179.9.6123.
11. Shivakoti R, Siwek M, Hauer D, Schultz KL, Griffin DE. 2013. Induction of dendritic cell production of type I and type III interferons by wild-type and vaccine strains of measles virus: role of defective interfering RNAs. J Virol 87:7816-7827. http://dx.doi.org/10.1128/JVI.00261-13.
12. Moss WJ, Griffin DE. 2012. Measles. Lancet 379:153-164. http://dx.doi.org/10.1016/S0140-6736(10)62352-5.
13. Naim HY. 2015. Measles virus: a pathogen, vaccine, and a vector. Hum Vaccin Immunother 11:21-26. http://dx.doi.org/10.4161/hv.34298.
14. Moss WJ. 2007. Measles still has a devastating impact in unvaccinated populations. PLoS Med 4:e24. http://dx.doi.org/10.1371/journal.pmed.0040024.
15. Lievano F, Galea SA, Thornton M, Wiedmann RT, ManoffSB, Tran TN, Amin MA, Seminack MM, Vagie KA, Dana A, Plotkin SA. 2012. Measles, mumps, and rubella virus vaccine (M-M-R™II): a review of 32 years of clinical and postmarketing experience. Vaccine 30:6918-6926. http://dx.doi.org/10.1016/j.vaccine.2012.08.057.
16. Bankamp B, Fontana JM, Bellini WJ, Rota PA. 2008. Adaptation to cell culture induces functional differences in measles virus proteins. Virol J 5:129. http://dx.doi.org/10.1186/1743-422X-5-129.
17. Takaki H, Watanabe Y, Shingai M, Oshiumi H, Matsumoto M, Seya T. 2011. Strain-to-strain difference of V protein of measles virus affects MDA5-mediated IFN-β-inducing potential. Mol Immunol 48:497-504. http://dx.doi.org/10.1016/j.molimm.2010.10.006.
18. Pfaller CK, Radeke MJ, Cattaneo R, Samuel CE. 2014. Measles virus C protein impairs production of defective copyback double-stranded viral RNA and activation of protein kinase R. J Virol 88:456-468. http://dx.doi.org/10.1128/JVI.02572-13.
19. Whistler T, Bellini WJ, Rota PA. 1996. Generation of defective interfering particles by two vaccine strains of measles virus. Virology 220:480-484. http://dx.doi.org/10.1006/viro.1996.0335.
20. Pathak KB, Nagy PD. 2009. Defective interfering RNAs: foes of viruses and friends of virologists. Viruses 1:895-919. http://dx.doi.org/10.3390/v1030895.
21. Calain P, Roux L. 1988. Generation of measles virus defective interfering particles and their presence in a preparation of attenuated live-virus vaccine. J Virol 62:2859-2866.
22. Kessler JR, Kremer JR, Muller CP. 2011. Interplay of measles virus with early induced cytokines reveals different wild type phenotypes. Virus Res 155:195-202. http://dx.doi.org/10.1016/j.virusres.2010.10.005.
23. Komarova AV, Combredet C, Sismeiro O, Dillies MA, Jagla B, Sanchez David RY, Vabret N, Coppée JY, Vidalain PO, Tangy F. 2013. Identification of RNA partners of viral proteins in infected cells. RNA Biol 10: 944-956. http://dx.doi.org/10.4161/rna.24453.
24. Plumet S, Herschke F, Bourhis JM, Valentin H, Longhi S, Gerlier D. 2007. Cytosolic 5'-triphosphate ended viral leader transcript of measles virus as activator of the RIG I-mediated interferon response. PLoS One 2:e279. http://dx.doi.org/10.1371/journal.pone.0000279.
25. Strahle L, Garcin D, Kolakofsky D. 2006. Sendai virus defectiveinterfering genomes and the activation of interferon-β. Virology 351:101-111. http://dx.doi.org/10.1016/j.virol.2006.03.022.
26. Baum A, Sachidanandam R, García-Sastre A. 2010. Preference of RIG-I for short viralRNAmolecules in infected cells revealed by next-generation sequencing. Proc Natl Acad Sci U S A 107:16303-16308. http://dx.doi.org/10.1073/pnas.1005077107.
27. Martinez-Gil L, GoffPH, Hai R, García-Sastre A, Shaw ML, Palese P. 2013. A Sendai virus-derived RNA agonist of RIG-I as a virus vaccine adjuvant. J Virol 87:1290-1300. http://dx.doi.org/10.1128/JVI.02338-12.
28. Ono N, Tatsuo H, Hidaka Y, Aoki T, Minagawa H, Yanagi Y. 2001. Measles viruses on throat swabs from measles patients use signaling lymphocytic activation molecule (CDw150) but not CD46 as a cellular receptor. J Virol 75:4399-4401. http://dx.doi.org/10.1128/JVI.75.9.4399-4401.2001.
29. Xu S, Zhang Y, Rivailler P, Wang H, Ji Y, Zhen Z, Mao N, Li C, Bellini WJ, Xu W, Rota PA. 2014. Evolutionary genetics of genotype H1 measles viruses in China from 1993 to 2012. J Gen Virol 95(Pt 9):1892-1899. http://dx.doi.org/10.1099/vir.0.066746-0.
30. Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, Uematsu S, Jung A, Kawai T, Ishii KJ, Yamaguchi O, Otsu K, Tsujimura T, Koh CS, Reis e Sousa C, Matsuura Y, Fujita T, Akira S. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441:101-105. http://dx.doi.org/10.1038/nature04734.
31. Marques JT, White CL, Peters GA, Williams BR, Sen GC. 2008. The role of PACT in mediating gene induction, PKR activation, and apoptosis in response to diverse stimuli. J Interferon Cytokine Res 28:469-476. http://dx.doi.org/10.1089/jir.2007.0006.
32. Kew C, Lui PY, Chan CP, Liu X, Au SWN, Mohr I, Jin DY, Kok KH. 2013. Suppression of PACT-induced type I interferon production by herpes simplex virus 1 Us11 protein. J Virol 87:13141-13149. http://dx.doi.org/10.1128/JVI.02564-13.
33. Lei T, Yuen KS, Tsao SW, Chen H, Kok KH, Jin DY. 2013. Perturbation of biogenesis and targeting of Epstein-Barr virus-encoded miR-BART3 microRNA by A-to-I editing. J Gen Virol 94:2739-2744. http://dx.doi.org/10.1099/vir.0.056226-0.
34. Bankamp B, Takeda M, Zhang Y, Xu W, Rota PA. 2011. Genetic characterization of measles vaccine strains. J Infect Dis 204(Suppl 1): S533-S548. http://dx.doi.org/10.1093/infdis/jir097.
35. Zuker M, Stiegler P. 1981. Optimal computer folding of large RNA sequences using thermodynamic and auxiliary information. Nucleic Acids Res 9:133-148. http://dx.doi.org/10.1093/nar/9.1.133.
36. Siu KL, Yeung ML, Kok KH, Yuen KS, Kew C, Lui PY, Chan CP, Tse H, Woo PCY, Yuen KY, Jin DY. 2014. Middle East respiratory syndrome coronavirus 4a protein is a double-stranded RNA-binding protein that suppresses PACT-induced activation of RIG-I and MDA5 in innate antiviral response. J Virol 88:4866-4876. http://dx.doi.org/10.1128/JVI.03649-13.
37. Tang HMV, Gao WW, Chan CP, Cheng Y, Chaudhary V, Deng JJ, Yuen KS, Wong CM, Ng IOL, Kok KH, Zhou J, Jin DY. 2014. Requirement of CRTC1 coactivator for hepatitis B virus transcription. Nucleic Acids Res 42:12455-12468. http://dx.doi.org/10.1093/nar/gku925.
38. Chaudhary V, Zhang S, Yuen KS, Li C, Lui PY, Fung SY, Wang PS, Chan CP, Li D, Kok KH, Liang M, Jin DY. 2015. Suppression of type I and type III interferon signalling by NSs protein of severe fever-withthrombocytopenia syndrome virus through inhibition of STAT1 phosphorylation and activation. J Gen Virol 96:3204-3211. http://dx.doi.org/10.1099/jgv.0.000280.
39. Kok KH, Jin DY. 2006. Influenza A virus NS1 protein does not suppress RNA interference in mammalian cells. J Gen Virol 87:2639-2644. http://dx.doi.org/10.1099/vir.0.81764-0.
40. Xiang JZ, Chen ZH. 1983. Measles vaccine in the People's Republic of China. Rev Infect Dis 5:506-510. http://dx.doi.org/10.1093/clinids/5.3.506.
41. Zhang Y, Zhou J, Bellini WJ, Xu W, Rota PA. 2009. Genetic characterization of Chinese measles vaccines by analysis of complete genomic sequences. J Med Virol 81:1477-1483. http://dx.doi.org/10.1002/jmv.21535.
42. Schoggins JW, Rice CM. 2011. Interferon-stimulated genes and their antiviral effector functions. Curr Opin Virol 1:519-525. http://dx.doi.org/10.1016/j.coviro.2011.10.008.
43. Runge S, Sparrer KM, Lässig C, Hembach K, Baum A, García-Sastre A, Söding J, Conzelmann KK, Hopfner KP. 2014. In vivo ligands of MDA5 and RIG-I in measles virus-infected cells. PLoS Pathog 10:e1004081. http://dx.doi.org/10.1371/journal.ppat.1004081.
44. Pfaller CK, Mastorakos GM, Matchett WE, Ma X, Samuel CE, Cattaneo R. 2015. Measles virus defective interfering RNAs are generated frequently and early in the absence of C protein and can be destabilized by adenosine deaminase acting on RNA-1-like hypermutations. J Virol 89:7735-7747. http://dx.doi.org/10.1128/JVI.01017-15.
45. Kato H, Takeuchi O, Mikamo-satoh E, Hirai R, Kawai T, Matsushita K, Hiiragi A, Dermody TS, Fujita T, Akira S. 2008. Length-dependent recognition of double-stranded ribonucleic acids by retinoic acidinducible gene-I and melanoma differentiation-associated gene 5. J Exp Med 205:1601-1610. http://dx.doi.org/10.1084/jem.20080091.
46. Ikegame S, Takeda M, Ohno S, Nakatsu Y, Nakanishi Y, Yanagi Y. 2010. Both RIG-I and MDA5 RNA helicases contribute to the induction of α/β interferon in measles virus-infected human cells. J Virol 84:372-379. http://dx.doi.org/10.1128/JVI.01690-09.
47. Shivakoti R, Hauer D, Adams RJ, Lin WH, Duprex WP, de Swart RL, Griffin DE. 2015. Limited in vivo production of type I or type III interferon after infection of macaques with vaccine or wild-type strains of measles virus. J Interferon Cytokine Res 35:292-301. http://dx.doi.org/10.1089/jir.2014.0122.
48. Bellocq C, Mottet G, Roux L. 1990. Wide occurrence of measles virus subgenomic RNAs in attenuated live-virus vaccines. Biologicals 18:337-343. http://dx.doi.org/10.1016/1045-1056(90)90039-3.
49. Yount JS, Gitlin L, Moran TM, López CB. 2008. MDA5 participates in the detection of paramyxovirus infection and is essential for the early activation of dendritic cells in response to Sendai virus defective interfering particles. J Immunol 180:4910-4918. http://dx.doi.org/10.4049/jimmunol.180.7.4910.
50. Schlee M, Roth A, Hornung V, Hagman CA, Wimmenauer V, Barchet W, Coch C, Janke M, Mihailovic A, Wardle G, Juranek S, Kato H, Kawai T, Poeck H, Fitzgerald KA, Takeuchi O, Akira S, Tuschl T, Latz E, Ludwig J, Hartmann G. 2009. Recognition of 5' triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus. Immunity 31:25-34. http://dx.doi.org/10.1016/j.immuni.2009.05.008.
51. Calain P, Roux L. 1993. The rule of six, a basic feature for efficient replication of Sendai virus defective interfering RNA. J Virol 67:4822-4830.
52. Luthra P, Ramanan P, Mire CE, Weisend C, Tsuda Y, Yen B, Liu G, Leung DW, Geisbert TW, Ebihara H, Amarasinghe GK, Basler CF. 2013. Mutual antagonism between the Ebola virus VP35 protein and the RIG-I activator PACT determines infection outcome. Cell Host Microbe 14:74-84. http://dx.doi.org/10.1016/j.chom.2013.06.010.
53. Tawaratsumida K, Phan V, Hrincius ER, High AA, Webby R, Redecke V, Häcker H. 2014. Quantitative proteomic analysis of the influenza A virus nonstructural proteins NS1 and NS2 during natural cell infection identifies PACT as an NS1 target protein and antiviral host factor. J Virol 88:9038-9048. http://dx.doi.org/10.1128/JVI.00830-14.
54. Kok KH, Jin DY. 2013. Balance of power in host-virus arms races. Cell Host Microbe 14:5-6. http://dx.doi.org/10.1016/j.chom.2013.07.004.
55. Bennett RL, Blalock WL, Choi EJ, Lee YJ, Zhang Y, Zhou YL, Oh SP, May WS. 2008. RAX is required for fly neuronal development and mouse embryogenesis. Mech Dev 125:777-785. http://dx.doi.org/10.1016/j.mod.2008.06.009.
56. Rowe TM, Rizzi M, Hirose K, Peters GA, Sen GC. 2006. A role of the double-stranded RNA-binding protein PACT in mouse ear development and hearing. Proc Natl Acad Sci U S A 103:5823-5828. http://dx.doi.org/10.1073/pnas.0601287103.
57. Dickerman BK, White CL, Chevalier C, Nalesso V, Charles C, Fouchécourt S, Guillou F, Viriot L, Sen GC, Hérault Y. 2011. Missense mutation in the second RNA binding domain reveals a role for Prkra (PACT/RAX) during skull development. PLoS One 6:e28537. http://dx.doi.org/10.1371/journal.pone.0028537.
58. Bennett RL, Blalock WL, Abtahi DM, Pan Y, Moyer SA, May WS. 2006. RAX, the PKR activator, sensitizes cells to inflammatory cytokines, serum withdrawal, chemotherapy, and viral infection. Blood 108:821-829. http://dx.doi.org/10.1182/blood-2005-11-006817.
59. Vitali P, Scadden AD. 2010. Double-stranded RNAs containing multiple IU pairs are sufficient to suppress interferon induction and apoptosis. Nat Struct Mol Biol 17:1043-1050. http://dx.doi.org/10.1038/nsmb.1864.
60. Yang S, Deng P, Zhu Z, Zhu J, Wang G, Zhang L, Chen AF, Wang T, Sarkar SN, Billiar TR, Wang Q. 2014. Adenosine deaminase acting on RNA 1 limits RIG-I RNA detection and suppresses IFN production responding to viral and endogenous RNAs. J Immunol 193:3436-3445. http://dx.doi.org/10.4049/jimmunol.1401136.
61. Mannion NM, Greenwood SM, Young R, Cox S, Brindle J, Read D, Nellåker C, Vesely C, Ponting CP, McLaughlin PJ, Jantsch MF, Dorin J, Adams IR, Scadden AD, Ohman M, Keegan LP, O'Connell MA. 2014. The RNA-editing enzyme ADAR1 controls innate immune responses to RNA. Cell Rep 9:1482-1494. http://dx.doi.org/10.1016/j.celrep.2014.10.041.
62. Ward SV, George CX, Welch MJ, Liou LY, Hahm B, Lewicki H, de la Torre JC, Samuel CE, Oldstone MBA. 2011. RNA editing enzyme adenosine deaminase is a restriction factor for controlling measles virus replication that also is required for embryogenesis. Proc Natl Acad Sci U S A 108:331-336. http://dx.doi.org/10.1073/pnas.1017241108.
63. Li Z, Okonski KM, Samuel CE. 2012. Adenosine deaminase acting on RNA 1 (ADAR1) suppresses the induction of interferon by measles virus. J Virol 86:3787-3794. http://dx.doi.org/10.1128/JVI.06307-11.
64. Okonski KM, Samuel CE. 2013. Stress granule formation induced by measles virus is protein kinase PKR dependent and impaired by RNA adenosine deaminase ADAR1. J Virol 87:756-766. http://dx.doi.org/10.1128/JVI.02270-12.
65. John L, Samuel CE. 2014. Induction of stress granules by interferon and down-regulation by the cellular RNA adenosine deaminase ADAR1. Virology 454-455:299-310. http://dx.doi.org/10.1016/j.virol.2014.02.025.
66. Gélinas JF, Clerzius G, Shaw E, Gatignol A. 2011. Enhancement of replication of RNA viruses by ADAR1 via RNA editing and inhibition of RNA-activated protein kinase. J Virol 85:8460-8466. http://dx.doi.org/10.1128/JVI.00240-11.
67. Rodriguez KR, Horvath CM. 2014. Paramyxovirus V protein interaction with the antiviral sensor LGP2 disruptsMDA5signaling enhancement but is not relevant to LGP2-mediated RLR signaling inhibition. J Virol 88: 8180-8188. http://dx.doi.org/10.1128/JVI.00737-14.
68. Irie T, Kiyotani K, Igarashi T, Yoshida A, Sakaguchi T. 2012. Inhibition of interferon regulatory factor 3 activation by paramyxovirus V protein. J Virol 86:7136-7145. http://dx.doi.org/10.1128/JVI.06705-11.
69. Sparrer KM, Pfaller CK, Conzelmann KK. 2012. Measles virus C protein interferes with β interferon transcription in the nucleus. J Virol 86:796-805. http://dx.doi.org/10.1128/JVI.05899-11.
70. Poole E, He B, Lamb RA, Randall RE, Goodbourn S. 2002. The V proteins of simian virus 5 and other paramyxoviruses inhibit induction of interferon-β. Virology 303:33-46. http://dx.doi.org/10.1006/viro.2002.1737.
71. Cattaneo R, Kaelin K, Baczko K, Billeter MA. 1989. Measles virus editing provides an additional cysteine-rich protein. Cell 56:759-764. http://dx.doi.org/10.1016/0092-8674(89)90679-X.
72. Russell SJ, Peng KW. 2009. Measles virus for cancer therapy. Curr Top Microbiol Immunol 330:213-241.